This indicates that high expression of SLC2A3 is associated with two immune escape mechanisms: dysfunction of tumor-infiltrating cytotoxic T lymphocytes (CTLs) and CTL rejection by immunosuppressive factors. This evidence concerns the gene SLC2A3 and neoplasm.